Skip to main content

Rahul Parikh, MD

Division of Clinical Radiation Oncology

​As a Board-certified Radiation Oncologist, Dr. Parikh is an Associate Professor in the Department of Radiation Oncology at the Rutgers Cancer Institute of New Jersey and Rutgers Robert Wood Johnson Medical School (RWJMS). He graduated Magna Cum Laude from an accelerated physician-scientist (BS/MD) program from Rensselaer Polytechnic Institute. He then went on to receive his medical degree from Albany Medical College in Albany, New York where he graduated with a distinction in research. Soon after, he returned to his home state of New Jersey and went on to complete his internship in Internal Medicine at Robert Wood Johnson Medical School. He continued his residency in Radiation Oncology at Robert Wood Johnson Medical School / Cancer Institute of New Jersey where he held the title of Chief Resident Physician. Prior to joining the faculty at Rutgers Cancer Institute of New Jersey, he served as the Director of Proton Therapy at the Icahn School of Medicine at Mount Sinai in New York City, where he specialized in the treatment of Lymphoma / Hematologic Malignancies and Adult and Pediatric Brain tumors. He has had the opportunity to conduct several clinical trials and present and co-author numerous clinical and translational papers in the oncology literature. His clinical and academic interests are to integrate patient reported outcomes to improve cancer care delivery and the health-related quality of life of cancer patients. He strives to optimize the use of intensity-modulated radiation therapy (IMRT), stereotactic radiosurgery (SRS), stereotactic body radiotherapy (SBRT), as well as proton beam therapy (PBT) in the management of his cancer patients. Currently, he serves as Director of Proton Beam Therapy at the Laurie Proton Therapy Center with Robert Wood Johnson University Hospital in partnership with the Rutgers Cancer Institute of New Jersey. With this position, he has helped to integrate the use of proton therapy into the multidisciplinary oncology treatment programs within the cancer center and across the Robert Wood Johnson Barnabas Health System. At Rutgers Cancer Institute of New Jersey, his primary research and clinical focus is in pediatric cancers, lymphoma / hematologic malignancies, and several disease sites using proton beam therapy (including pediatrics, skull base tumors, brain tumors-benign and malignant). He has a strong research interest in the outcomes of patients treated with advanced radiotherapy modalities. He is also the Fellowship Director for the Precision Radiation Oncology training program, aimed to provide specialty training for international radiation oncology graduates. In addition to his clinical and academic practice at Rutgers Cancer Institute of New Jersey, he holds several national and international leadership roles within committees in ASTRO (American Society for Therapeutic Radiation Oncology), steering committee member of the International Lymphoma Radiation Oncology Group (ILROG), and on several committees of the Particle Therapy Co-Operative Group (PTCOG), American Society for Clinical Oncology (ASCO), and American Radium Society (ARS). He is also an active member of several co-operative groups including: Radiation Therapy Oncology Group (RTOG), Proton Collaborative Group (PCG), and Children’s Oncology Group (COG). He also serve as an active peer reviewer and on the editorial board for several oncology focused journals, including the Journal of Clinical Oncology and International Journal of Radiation Oncology, Biology, and Physics. A New Jersey native, Dr. Parikh enjoys traveling, golf, and beach sports with his family.

 

Awards

  • Moderator, Lymphoma Scientific Session, ASTRO (American Society for Therapeutic Radiation Oncology), September 2019
  • Grant Award PI: Precision Radiation Oncology Fellowship for International Fellows, July 2018
  • American Board of Radiology (ABR), written and oral board examiner, 2018 – current
  • Chair, Cancer Committee of Robert Wood Johnson University Hospital/Rutgers-CINJ, 2016 – current
  • Rutgers Robert Wood Johnson Medical School, Admissions Committee, Appointed Membership, 2016 – 2020
  • Moderator, Lymphoma Scientific Session, ASTRO (American Society for Therapeutic Radiation Oncology), October 2015
  • Clinical Research Award Travel Grant, ASTRO Travel Grant to 57th Annual Meeting, San Antonio, TX. October 2015
  • Moderator, Lymphoma Session, ARS (American Radium Society), May 2015
  • Best Publication by Resident In-Training, June 2013
  • UMDNJ/RWJMS Dean’s Research Award, May 2011 National Roentgen Resident/Fellow Research Award, June 2010
  • 1st Place Award for Commission on Cancer (COC), 2009 Cancer Paper Competition, American College of Surgeons, May 2009
  • Best Publication by Resident In-Training, UMDNJ/RWJMS Dean’s Research Award, May 2009
  • Resident Appreciation Award, Arnold P. Gold Humanism in Medicine Foundation, May 2009
  • Travel Grant, American Radium Society, Annual Meeting, Vancouver, CA, April 2009